Cited by 115Tryptophan and brain disordersAutism Spectrum Disorder ResearchNeuroinflammation and Neurodegeneration Mechanisms

Bridging autism spectrum disorders and schizophrenia through inflammation and biomarkers – pre-clinical and clinical investigations

Open access
Prata, Joana, Santos, Susana G., Almeida, Maria Inês, Coelho, Rui, Barbosa, Mário A.·2017·Journal of Neuroinflammation

Abstract

In recent years, evidence supporting a link between inflammation and neuropsychiatric disorders has been mounting. Autism spectrum disorders (ASD) and schizophrenia share some clinical similarities which we hypothesize might reflect the same biological basis, namely, in terms of inflammation. However, the diagnosis of ASD and schizophrenia relies solely on clinical symptoms, and to date, there is no clinically useful biomarker to diagnose or monitor the course of such illnesses.The focus of this review is the central role that inflammation plays in ASD and schizophrenia. It spans from pre-clinical animal models to clinical research and excludes in vitro studies. Four major areas are covered: (1) microglia, the inflammatory brain resident myeloid cells, (2) biomarkers, including circulating cytokines, oxidative stress markers, and microRNA players, known to influence cellular processes at brain and immune levels, (3) effect of anti-psychotics on biomarkers and other predictors of response, and (4) impact of gender on response to immune activation, biomarkers, and response to anti-psychotic treatments.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12974-017-0938-y

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In neurodevelopmental disorders, microglia can have impaired pruning or secrete molecules that contribute to CNS hyperactivity.

    “Although not as clear in neurodevelopmental disorder, microglia can have impaired pruning or secrete molecules that contribute to hyperactivity in the CNS [7, 9].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 275 · Cited by 115

Research works printed but not linked: 1

  1. [218]Stahl SM. Neuroscientific basis and practical applications. 4th Edition ed. 2013; Cambridge: Cambridge University Press. Essent Psychopharmacol.

Authors
Prata, J., Santos, S. G., Almeida, M. I., Coelho, R., & Barbosa, M. A.
Affiliations
Universidade do Porto (PT)
Corresponding author
Santos, Susana G.
Venue
Journal of Neuroinflammation
Published
2017-09-04
Volume
14
Issue
1
Pages
179-179
ISSN
1742-2094 (ISSN-L)
OpenAlex
W2751434657
Cited by
115
References
275
Citations by year
2026: 3 · 2025: 7 · 2024: 10 · 2023: 12 · 2022: 15 · 2021: 13 · 2020: 19 · 2019: 20 · 2018: 16
FWCI
1.02
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of Neuroinflammation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
autism spectrum disorder, schizophrenia, neuroinflammation, biomarkers, microglia, serum cytokines, oxidative stress, microRNA, antipsychotic treatment response, gender differences, immune activation, animal models
MeSH terms
Autism Spectrum Disorder, Animals, Clinical Trials as Topic, Humans, Inflammation, RNA, Messenger, Schizophrenia, Antipsychotic Agents, Biomarkers, Cytokines, Microglia, Oxidative Stress, Inflammation Mediators

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review